Skip to main content
Cancer Explained

Disponible en español: Detección del cáncer de próstata: cómo tomar la decisión con su médico

Beginner 8 min read Verified

Prostate Cancer Screening: Making the Decision With Your Doctor

A plain-language guide to the shared decision behind prostate cancer screening, including the PSA test, digital rectal exam, benefits and harms, and USPSTF guidance for ages 55 to 69, grounded in the National Cancer Institute PSA fact sheet.

NCI source

Last reviewed: 2026-07-04

The short answer

Prostate cancer screening is not automatic; it is a personal decision. The main tool is the PSA blood test, sometimes with a rectal exam. Screening may catch cancer early, but it also carries harms like false positives and overdiagnosis. Expert guidance says men aged 55 to 69 should decide with their doctor after weighing the benefits and harms.

  • Prostate cancer screening is a shared decision, not a routine test everyone gets.

  • The main screening tool is the PSA blood test, sometimes with a digital rectal exam.

  • For men aged 55 to 69, expert guidance says the decision to screen should be individual.

  • Routine PSA screening is generally not recommended for men 70 and older.

Choose how you want to understand this

The full explanation.

The simple version

Prostate cancer screening is different from many other screenings. There is no age when it simply happens to everyone. Instead, it is a personal decision you make together with your doctor.

The main tool is a blood test called the PSA test, sometimes paired with a physical exam of the prostate. The reason screening is a decision, and not automatic, is that it has real benefits and real downsides that have to be weighed against each other.

Prostate cancer screening is a shared decision, not a routine test for all.

The tests used

Two tests are commonly involved in prostate cancer screening.

  • The PSA test measures the level of prostate-specific antigen, a protein made by the prostate, in a blood sample. Higher levels can be a sign of cancer, but many other things can raise PSA too.
  • The digital rectal exam (DRE) is when a doctor gently feels the prostate through the wall of the rectum, checking for lumps or hard areas.

Neither test diagnoses cancer by itself. If a result is concerning, the doctor may repeat the PSA, order other tests, or recommend a prostate biopsy to check the tissue directly.

These tests raise or lower suspicion; they do not diagnose cancer on their own.

What "high PSA" really means

It is easy to assume a high PSA means cancer, but that is not the case. There is no single number that means someone has prostate cancer.

Many things besides cancer can raise PSA, including an enlarged prostate (a common change with age), a prostate infection or inflammation, a recent exam or biopsy, and even vigorous cycling or recent ejaculation. Some medicines can lower PSA.

Because of this, a raised PSA usually leads to a repeat test in a few weeks or to further evaluation, not to an immediate diagnosis.

A high PSA is a reason to look closer, not proof of cancer.

The expert guidance

The U.S. Preventive Services Task Force, a group of independent experts, offers clear guidance on who should consider screening.

  • For men aged 55 to 69, the decision to have periodic PSA screening should be an individual one. Before deciding, a man should discuss the benefits and harms with his doctor and consider his own values and preferences.
  • For men 70 and older, routine PSA screening is generally not recommended.

Some organizations also suggest that men at higher risk, such as Black men, men with a family history of prostate cancer, or men with certain inherited gene changes, begin these conversations earlier, around age 40 or 45.

Ages 55 to 69 is where the decision is most clearly an individual one.

Weighing benefits and harms

The reason this is a decision, rather than a routine test, comes down to a balance.

The benefit is that screening may find prostate cancer earlier, when it may be easier to treat, and can slightly lower the chance of dying from prostate cancer over time.

The harms are important too:

  • False positives. A raised PSA when there is no cancer is common. It can cause anxiety and lead to a biopsy, which carries small risks like infection, pain, or bleeding.
  • Overdiagnosis. Some prostate cancers grow so slowly they would never cause harm. Screening can find these, and treating them, called overtreatment, can bring side effects such as urinary, bowel, or sexual problems.
  • No guarantee. Finding cancer early does not always lead to a cure, since some cancers may have already spread.

For men who prefer to avoid these downsides, choosing not to screen is a valid choice. For men who most want the chance to catch a cancer early, screening may be worth it. Both can be reasonable.

The right choice depends on your values, your risk, and a real conversation with your doctor.

A note on the PSA test itself

This article focuses on the decision to screen. If you want a closer look at how the PSA test works, what the numbers mean, and how it is used after a diagnosis, see our companion article on the PSA test. Together, the two give you a fuller picture as you talk with your care team.

Words to know

Tap any term to see what it means.

Browse the full glossary →

Common questions

What tests are used to screen for prostate cancer?

The main one is the PSA (prostate-specific antigen) blood test, which measures a protein made by the prostate. A doctor may also do a digital rectal exam, feeling the prostate through the rectum for lumps. Neither test diagnoses cancer on its own; an abnormal result may lead to more tests.

What does the expert guidance say about who should be screened?

The U.S. Preventive Services Task Force says that for men aged 55 to 69, the decision to have PSA screening should be an individual one made with a doctor after weighing the benefits and harms. For men 70 and older, routine PSA screening is generally not recommended.

What are the benefits of screening?

Screening may find prostate cancer earlier, when it may be easier to treat, and can slightly reduce the chance of dying from prostate cancer over time. For some men, catching a serious cancer early makes a real difference.

What are the harms of screening?

PSA screening can give false positives, leading to worry and to biopsies that carry small risks like infection or bleeding. It can also find slow-growing cancers that would never have caused harm, a problem called overdiagnosis, which can lead to unnecessary treatment with side effects.

Does a high PSA mean I have cancer?

No. Many things besides cancer can raise PSA, including an enlarged prostate, infection, inflammation, a recent exam, or even vigorous cycling. A raised PSA usually leads to repeat testing or more evaluation, not an automatic cancer diagnosis.

Are some men at higher risk?

Yes. Black men, men with a father or brother who had prostate cancer, and men with certain inherited gene changes such as in BRCA2 are at higher risk. Some organizations suggest these men start the screening conversation earlier, around age 40 or 45.

Questions to ask your doctor

Being prepared helps you get the most out of your appointments. Save or print these questions.

Open my question list

Tap a question to save it to your list (kept on this device).

Quick quiz

Test your knowledge

0 of 4 answered

  1. Q1.According to this article, what is the main tool used for prostate cancer screening?
  2. Q2.According to this article, what does the U.S. Preventive Services Task Force say about men aged 55 to 69?
  3. Q3.According to this article, does a high PSA mean a person has cancer?
  4. Q4.According to this article, what are some of the harms of prostate cancer screening?

This quiz checks understanding of educational content only. It is not medical advice. Open this quiz on its own page.

Related learning map

How this explanation connects to 13 other things you can explore — related topics, terms, questions, practice, and its NCI source.

Prostate Cancer Screening: Making the Decision With Your Doctor